Ironwood Pharmaceuticals, Inc. (IRWD) earnings per share (EPS)

Earnings per share · fiscal 2025
$0.15

Ironwood Pharmaceuticals, Inc. (IRWD) reported diluted earnings per share of $0.15 in fiscal 2025 (the year ended December 31, 2025). That is 1400.0% higher than the $0.01 of fiscal 2024. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$0.15
Change on fiscal 2024
+1400.0%
Growth, 5 years
−25.6% a year
Highest on record
$3.21fiscal 2021
Lowest on record
-$6.45fiscal 2023
Fiscal years on record
112011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ironwood Pharmaceuticals, Inc. earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 25.6% a year. Across the 11 fiscal years on record (2011–2025), the highest was $3.21 in fiscal 2021 and the lowest -$6.45 in fiscal 2023.

History · 11 fiscal years

Earnings per share by fiscal year

Ironwood Pharmaceuticals, Inc. earnings per share (EPS), year by year

Ironwood Pharmaceuticals, Inc. (IRWD) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$0.15 1,400.0% up
2024$0.01—
2023-$6.45 771.9% down
2022$0.96 70.1% down
2021$3.21 386.4% up
2020$0.66 371.4% up
2019$0.14—
2018-$1.85—
2013-$1.97—
2012-$0.57—
2011-$0.54—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on IRWD

Ironwood Pharmaceuticals, Inc., figure by figure

Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard

Ironwood Pharmaceuticals, Inc. earnings per share (EPS): questions and answers

What is Ironwood Pharmaceuticals, Inc.'s diluted earnings per share?

Ironwood Pharmaceuticals, Inc. (IRWD) reported diluted earnings per share of $0.15 in fiscal 2025 (the year ended December 31, 2025). That is 1400.0% higher than the $0.01 of fiscal 2024.

What is the growth rate of Ironwood Pharmaceuticals, Inc.'s diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 25.6% a year.

What are the highest and lowest diluted earnings per share figures on record for Ironwood Pharmaceuticals, Inc.?

Across the 11 fiscal years on record (2011–2025), the highest was $3.21 in fiscal 2021 and the lowest -$6.45 in fiscal 2023.

How is Ironwood Pharmaceuticals, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Ironwood Pharmaceuticals, Inc. it is on record here for 11 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.